Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eiaOCfbwoceZjcvliaxd

January 22, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
 Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
 

  Legislative & Regulatory News 
  • Health insurers may limit participation in state exchanges
    The extent to which insurers will participate in state health insurance exchanges mandated by the Affordable Care Act remains to be seen, experts say. States are allowed to vary in their exchange requirements for insurers, and the companies will also have to pay federally mandated fees and taxes, this article notes. "We will only participate in exchanges that we assess to be fair, commercially sustainable and provide a reasonable return on the capital they will require," says Stephen Hemsley, CEO of UnitedHealth Group, adding that the company expects to participate initially in 10 to 25 exchanges. Omaha World-Herald (Neb.)/The Associated Press (1/20) LinkedInFacebookTwitterEmail this Story
  • ACA is on the table in debt talks
    Republicans and Democrats negotiating the nation's debt limit and budget may be tempted to cut more Affordable Care Act funding. Potential actions include requiring 100% repayment of insurance subsidy overpayments, delaying Medicaid expansion and health insurance marketplaces, and blending the Medicaid reimbursement rate with that of other federal programs. Politico (Washington, D.C.) (1/22) LinkedInFacebookTwitterEmail this Story
  • Other News
  Drug Industry Spotlight 
  • 6 states consider bills regarding biosimilars
    Six states are weighing bills involving the interchangeability of biosimilars and brand-name biologics. In Virginia, a legislative panel endorsed a bill that would authorize pharmacists to dispense biosimilars that the FDA considers interchangeable, while a Pennsylvania lawmaker says rules on generics aren't applicable to biosimilars and new legislation is needed. In 2012, changes were proposed to Illinois' Pharmacy Practice Act, while Indiana, North Dakota and Texas also are considering bills. Pharmalot.com/Pharma Blog (1/18) LinkedInFacebookTwitterEmail this Story
  • Other News
  SmartQuote 
It ain't what they call you, it's what you answer to."
--W.C. Fields,
American comedian, actor and writer


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information